Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.46 |
| ▸ | CASP1 | P29466 | 1/20 | 0.46 |
| ▸ | CASP7 | P55210 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 3/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | POLB | P06746 | 2/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | RECQL | P46063 | 2/20 | 0.42 |
| ▸ | CASP6 | P55212 | 2/20 | 0.42 |
| ▸ | ELAVL1 | Q15717 | 1/20 | 0.42 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.40 |
| ▸ | SUMO2 | P61956 | 2/20 | 0.38 |
| ▸ | SUMO1 | P63165 | 2/20 | 0.38 |
| ▸ | SENP7 | Q9BQF6 | 2/20 | 0.38 |
| ▸ | SENP2 | Q9HC62 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11337312 | 0.89 | ALDH1A1 (0.50) | ALDH1A1TDP1HSD17B10CASP1CASP7 | |
| SCHEMBL30922153 | 0.83 | ALDH1A1 (0.46) | ALDH1A1TDP1HSD17B10CASP1CASP7 | |
| SCHEMBL9680119 | 0.83 | TDP1 (0.47) | ALDH1A1TDP1HSD17B10CASP1CASP7 | |
| SCHEMBL10847621 | 0.83 | ALDH1A1 (0.46) | ALDH1A1TDP1HSD17B10CASP1CASP7 | |
| SCHEMBL15449420 | 0.82 | ALDH1A1 (0.58) | ALDH1A1TDP1HSD17B10CASP1CASP7 | |
| SCHEMBL2435832 | 0.81 | L3MBTL1 (0.59) | ALDH1A1KDM4EL3MBTL1MEN1KMT2A | |
| SCHEMBL176785 | 0.80 | ALDH1A1 (0.44) | ALDH1A1TDP1HSD17B10CASP1CASP7 | |
| SCHEMBL18538523 | 0.80 | ALDH1A1 (0.43) | ALDH1A1TDP1HSD17B10CASP1CASP7 | |
| SCHEMBL2884819 | 0.78 | CA1 (0.42) | ALDH1A1TDP1KDM4EL3MBTL1MEN1 | |
| SCHEMBL13214335 | 0.77 | ALDH1A1 (0.67) | ALDH1A1TDP1HSD17B10CASP1CASP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE49569-E1 | Alkylamine derivative | EA PHARMA CO., LTD. (JP) | 2023-07-04 | — | — | US | disclosed |
| EP-2546231-B1 | ALKYLAMINE DERIVATIVE | EA PHARMA CO LTD (JP) | 2018-11-07 | — | — | EP | disclosed |
| US-9561216-B2 | Alkylamine derivative | EA PHARMA CO., LTD. (JP) | 2017-02-07 | — | — | US | disclosed |
| US-20160101091-A1 | ALKYLAMINE DERIVATIVE | AJINOMOTO CO., INC. (JP) | 2016-04-14 | — | — | US | disclosed |
| US-9253997-B2 | Alkylamine derivative | AJINOMOTO CO., INC. (JP) | 2016-02-09 | — | — | US | disclosed |
| US-9150505-B2 | Prophylactic or therapeutic agent for diabetes or obesity | AJINOMOTO CO., INC. (JP) | 2015-10-06 | — | — | US | disclosed |
| US-20130237702-A1 | ALKYLAMINE DERIVATIVE | AJINOMOTO CO., INC. (JP) | 2013-09-12 | — | — | US | disclosed |
| US-20130072491-A1 | PROPHYLACTIC OR THERAPEUTIC AGENT FOR DIABETES OR OBESITY | AJINOMOTO CO., INC. (JP) | 2013-03-21 | — | — | US | disclosed |
| EP-2546231-A1 | ALKYLAMINE DERIVATIVE | Ajinomoto Co., Inc. (JP) | 2013-01-16 | — | — | EP | disclosed |
| EP-2543660-A1 | PROPHYLACTIC OR THERAPEUTIC AGENT FOR DIABETES OR OBESITY | Ajinomoto Co., Inc. (JP) | 2013-01-09 | — | — | EP | disclosed |
| WO-2005121204-A2 | POLYHYDROXYALKANOIC ACID HAVING VINYL, ESTER, CARBOXYL OR SULFONIC ACID GROUP AND PRODUCING METHOD THEREFOR | CANON KABUSHIKI KAISHA (JP) | 2005-12-22 | — | — | WO | disclosed |
| WO-2005121904-A1 | CHARGE CONTROL AGENT, TONER, IMAGE FORMING METHOD, AND IMAGE FORMING APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2005-12-22 | — | — | WO | disclosed |
| WO-2005121205-A2 | POLYHYDROXYALKANOATE HAVING ESTER GROUP, CABOXYL GROUP, AND SULFONIC GROUP, AND METHOD OF PRODUCING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2005-12-22 | — | — | WO | disclosed |
| WO-2005108441-A2 | POLYMER HAVING A SULFONIC GROUP OR A SULFONATE GROUP AND AN AMIDE GROUP AND METHOD OF PRODUCING SAME | CANON KABUSHIKI KAISHA (JP) | 2005-11-17 | — | — | WO | disclosed |
| EP-1579277-A1 | POLYHYDROXYALKANOATE CONTAINING AMIDE GROUP, SULFONIC GROUP, AND SULFONATE ESTER GROUP, METHOD FOR PRODUCING THE SAME, AND CHARGE CONTROL AGENT, TONER, IMAGE FORMING METHOD, AND IMAGE FORMING APPARATUS | Canon Kabushiki Kaisha (JP) | 2005-09-28 | — | — | EP | disclosed |
| EP-1579276-A1 | NOVEL POLYHYDROXYALKANOATE HAVING AMIDE, SULFONIC ACID OR SULFONATE ESTER GROUP, CHARGE CONTROL AGENT AND TONER | CANON KABUSHIKI KAISHA (JP) | 2005-09-28 | — | — | EP | disclosed |
| WO-2004061530-A1 | POLYHYDROXYALKANOATE CONTAINING AMIDE GROUP, SULFONIC GROUP, AND SULFONATE ESTER GROUP, METHOD FOR PRODUCING THE SAME, AND CHARGE CONTROL AGENT, TONER, IMAGE FORMING METHOD, AND IMAGE FORMING APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2004-07-22 | — | — | WO | disclosed |
| WO-2004061529-A1 | NOVEL POLYHYDROXYALKANOATE HAVING AMIDE, SULFONIC ACID OR SULFONATE ESTER GROUP, CHARGE CONTROL AGENT AND TONER | CANON KABUSHIKI KAISHA (JP) | 2004-07-22 | — | — | WO | disclosed |
| EP-1091958-A1 | SALTS OF PAROXETINE | SMITHKLINE BEECHAM PLC (GB) | 2001-04-18 | — | — | EP | disclosed |
| WO-2000001692-A1 | SALTS OF PAROXETINE | SMITHKLINE BEECHAM PLC (GB) | 2000-01-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130072491-A1 | PROPHYLACTIC OR THERAPEUTIC AGENT FOR DIABETES OR OBESITY | CASR, GPR119, GLP1R | ALDH1A1 2305/4885TDP1 4149/4885HSD17B10 2719/4885 |
| US-20160101091-A1 | ALKYLAMINE DERIVATIVE | CASR, TAAR5, TAAR1 | ALDH1A1 2451/4885TDP1 1976/4885HSD17B10 2174/4885 |
| US-20130237702-A1 | ALKYLAMINE DERIVATIVE | CASR, TAAR5, TAAR1 | ALDH1A1 2451/4885TDP1 1976/4885HSD17B10 2174/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.